摘要
临床药师参与1例儿童活体肝移植术后的抗凝治疗过程,深入分析影响患儿抗凝疗效的因素,结合患儿的病理生理特点,从药物选择、给药剂量、合并用药等方面提出个体化建议,临床医师采纳建议,患者经治疗后国际标准化比值(INR)控制在目标范围内,病情平稳出院。
Clinical pharmacists participated in the anticoagulant treatment process of a child after living donor liver transplantation,and the factors affecting the anticoagulant efficacy were thoroughly analyzed.According to the physiological and pathological characteristics of the patient,clinical pharmacists provided medical advice for clinicians in terms of drug choice,dosage and drug interactions.The clinicians adopted the recommendations,and the patient’s INR was within the target range after treatment and discharged with steady condition.
作者
林忠秋
刘滔滔
张宏亮
丘岳
陈依雨
Lin Zhongqiu;Liu Taotao;Zhang Hongliang;Qiu Yue;Chen Yiyu(Department of Pharmacy,the First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China)
出处
《中国药师》
CAS
2020年第11期2199-2202,共4页
China Pharmacist
基金
广西壮族自治区卫生健康委员会自筹经费科研课题(编号:Z20200498)。
关键词
儿童
活体肝移植
抗凝
华法林
药学监护
Child
Living donor liver transplantation
Anticoagulant
Warfarin
Pharmaceutical monitoring